9
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Nevus Cells and Special Nevomelanocytic Lesions in Children

, , &
Pages 1029-1041 | Received 01 Apr 1994, Accepted 06 May 1994, Published online: 09 Jul 2009

References

  • Weston J A. The migration and differentiation of neural crest cells. Adv Morphog 1970; 8: 41–114
  • Magana-Garcia M, Ackerman B. What are nevus cells?. Am J Dermatopathol 1990; 12: 93–102
  • Alpert J C, Holmes L B. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol 1983; 1: 58–68
  • Walton R, Jacobs A, Cox A. Pigmented lesions in newborn infants. Br J Dermatol 1976; 95: 389–96
  • Green A, Swerdlow A J. Epidemiology of melanocytic nevi. Epidemiol Rev 1989; 11: 204–11
  • Ruiz-Maldonado R, Tarmayo L, Laterza A M, Duran C. Giant pigmented nevi: Clinical, histopathologic, and therapeutic considerations. J Pediatr 1992; 120: 906–11
  • Pope D J, Sorahan T, Marsden J R. Benign pigmented nevi in children. Arch Dermatol 1992; 128: 1201–6
  • Mark G J, Mihm M C, Liteplo M G, Reed R J, Clark W H. Congenital melanocytic nevi of the small and garment type. Hum Pathol 1973; 4: 395–418
  • Lanier V C, Pickrell K L, Georgiade N G. Congenital giant nevi: Clinical and pathological considerations. Plast Reconstr Surg 1976; 58: 48–54
  • Silvers D N, Helwig E B. Melanocytic nevi in neonates. J Am Acad Dermatol 1981; 4: 166–75
  • Nickoloff B J, Walton R, Pregerson-Rodan K, Jacobs A H, Cox A J. Immunohistologic patterns of congenital nevocellular nevi. Arch Dermatol 1985; 122: 1263–8
  • Rhodes A R. Congenital nevomelanocytic nevi. Arch Dermatol 1986; 122: 1257–62
  • Clemmensen O J, Kroon S. The histology of “congenital features” in early acquired melanocytic nevi. J Am Acad Dermatol 1988; 19: 742–6
  • Stenn K S, Arons M, Kurwitz S. Patterns of congenital nevocellular nevi. J Am Acad Dermatol 1983; 9: 388–93
  • Walsh M Y, Mackie R M. Histological features of value in differentiating small congenital melanocytic naevi from acquired naevi. Histopathology 1988; 12: 145–54
  • Angelucci A, Natali P G, Amerio P L, Ramenghi M. Rapid perinatal growth mimicking malignant transformation in a giant congenital melanocytic nevus. Hum Pathol 1991; 22: 297–301
  • Reyes-Mugica M, Gonzalez-Crussi F, Bauer B S, Medina-Escobedo G. Bulky naevocytoma of the perineum: A singular variant of congenital giant pigmented naevus. Virchows Arch [A] 1992; 420: 87–93
  • Kissel P, André J M, Jacquier A. The neurocristopathies. Masson, New York 1981; 210–3
  • Kadonaga J N, Frieden I J. Neurocutaneous melanosis: Definition and review of the literature. J Am Acad Dermatol 1991; 24: 747–55
  • Yamazaki K, Ohmori T, Kumagai Y, Makuuchi H, Eyden B. Ultrastructure of oesophageal melanocytosis. Virchows Arch [A] 1991; 418: 515–22
  • Reyes-Mugica M, Chou P, Byrd S. Nevomelanocytic proliferations in the central nervous system of children. Cancer 1993; 72: 2277–85
  • Crisp D E, Thompson J A. Primary malignant melanomatosis of the meninges. Arch Neurol 1981; 38: 528–9
  • Humes R A, Roskamp J, Eisenbrey A B. Melanosis and hydrocephalus: Report of four cases. J Neurosurg 1984; 61: 365–8
  • Faillace W J, Akawara S H, McDonald J V. Neurocutaneous melanosis with extensive intracerebral and spinal involvement. J Neurosurg 1984; 61: 782–5
  • Yu H S, Tsaur K C, Chien C H. Neurocutaneous melanosis: Electron microscopic comparison of the pigmented melanocytic nevi of skin and meningeal melanosis. J Dermatol 1985; 12: 267–76
  • Alvarez-Franco M, Vicari F A, Reyes-Mugica M, Bauer B S, Paller A S. Culture of giant congenital pigmented nevi: Immunohistochemical and electron microscopic studies. J Invest Dermatol 1992; 98: 648
  • Case 28–1992. N Engl J Med 1992; 327: 107–16
  • Halaban R, Ghosh S, Duray P. Human melanocytes cultured from nevi and melanoma. J Invest Dermatol 1986; 87: 95–101
  • Herlyn M, Rodeck U, Mancianti M L. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. Cancer Res 1987; 47: 3057–61
  • Gilchrest B A, Treloar V, Grassi A M. Characteristics of cultivated adult human nevocellular nevus cells. J Invest Dermatol 1986; 87: 102–7
  • Fimiani M, Mancianti M L, Flori M L. Culture di nevi nevocellulari. Boll Soc Ital Biol Sper 1981; 57: 1916–20
  • Aubert C, Amar R, Rouge F, Bureau H. Intérét de l'étude biologique des cultures de cellules issues de naevi pigmentaires bénins: Étude préliminaire. Ann Chir Plast 1976; 21: 271–6
  • Mancianti M L, Herlyn M, Weil D. Growth and phenotypic characteristics of human nevus cells in culture. J Invest Dermatol 1988; 90: 134–41
  • Herlyn M, Herlyn D, Elder D E. Phenotypic characteristics of cells derived from precursors of human melanoma. Cancer Res 1983; 43: 5502–8
  • Gown A M, Vogel A M, Hoak D. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1986; 123: 195–203
  • Nakajima T, Watanabe S, Sato Y. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus and its diagnostic application. Cancer 1982; 50: 912–8
  • Brooks J J, Perosio P H. Adipose Tissue. Histology for Pathologists, S S Sternberg. Raven Press. 1992; 33–60
  • Ordoñez N G, Xiaolong J I, Hickey R C. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988; 90: 385–90
  • Raffaelli M, Fimiani M, Castelli A. Impiégo dell'anticorpo monoclonale 225.28S nello studio delle cellule neviche in coltura. Boll Soc Ital Biol Sper 1984; 60: 467–71
  • Wilson B S, Imai K, Natali P G, Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 1981; 28: 293–300
  • Maeda K, Jimbow K. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes. Cancer 1987; 59: 415–23
  • Nakanishi T, Hashimoto K. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1. Cancer 1987; 59: 1340–4
  • Imam A, Mitchell M S, Modlin R L. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections. J Invest Dermatol 1986; 86: 145–8
  • Wick M R, Stanley S J, Swanson P E. Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti-synaptophysin. Arch Pathol Lab Med 1988; 112: 616–20
  • Skelton H G, Smith K J, Barret T L. HMB-45 staining in benign and malignant melanocytic lesions: A reflection of cellular activation. Am J Dermatopathol 1991; 13: 543–50
  • Taatjes D J, Arendash-Durand B, von Turkovicj M, Trainer T D. HMB-45 Antibody demonstrates melanosome specificity by immunoelectron microscopy. Arch Pathol Lab Med 1993; 117: 264–8
  • Kapur R P, Bigler S A, Skelly M, Gown A M. Anti-melanoma monoclonal antibody HMB45 identified an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem 1992; 40: 207–12
  • Yaar M, Woodley D T, Gilchrest B A. Human nevocellular nevus cells are surrounded by basement membrane components: Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest 1988; 58: 157–62
  • Flowers J L, Seigler H F, McCartey K S. Absence of estrogen receptors in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody. Arch Dermatol 1987; 123: 764–5
  • Feucht K A, Walker M J, Das Gupta T K, Beattie C W. Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice. Cancer Res 1988; 48: 7093–101
  • Ellis D L, Wheeland R G, Solomon H. Estrogen and progesterone receptors in melanocytic lesions: Occurrence in patients with dysplastic nevus syndrome. Arch Dermatol 1985; 121: 1282–5
  • Ellis D L, Wheeland R G, Solomon H. Estrogen and progesterone receptors in congenital melanocytic nevi. J Am Acad Dermatol 1985; 12: 235–44
  • Fisher R I, Neifeld J P, Lippman M E. Estrogen receptors in human malignant melanoma. Lancet 1976; 14: 337–8
  • McCarty K S, Jr, Miller L S, Coxs E B. Ostrogen receptor analyses: Correlation of biochemical and immunohistochemical methods using monoclonal antireceptors antibodies. Arch Pathol Lab Med 1985; 109: 716–21
  • McCarty K S, Jr, Wortman J, Stowers S. Sex steroid receptor analysis in human melanoma. Cancer 1980; 46: 1463–70
  • Zava D T, Goldhirsch A. Estrogen receptor in malignant melanoma: Fact or artefact?. Eur J Cancer Clin Oncol 1983; 19: 1151–9
  • Lecavalier M A, From L, Gaid N. Absence of estrogen receptors in dysplastic nevi and malignant melanoma. J Am Acad Dermatol 1990; 23: 242–6
  • Delarue J C, Avril M F, Charpentier P, Prade M. Estrogen receptors in malignant melanoma. Arch Dermatol 1987; 123: 159–60
  • Schad C R, Kraker W J, Jalal S M. Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders. Am J Clin Pathol 1991; 96: 203–10
  • Trask B J. DNA sequence localization in metaphase and interphase cells by fluorescent in situ hybridization. Methods Cell Biol 1991; 35: 3–35
  • Alvarez-Franco M, Vicari F A, Bauer B S, Reyes-Mugica M. Extra-chromosome 7 is present in congenital pigmented nevi. Abstract. Pediatr Pathol 1994; 14: 539
  • Koprowski H, Herlyn M, Balaban G, Parmiter A, Ross A, Nowell P. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat Cell Mol Genet 1985; 11: 297–302

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.